NCT06540326 2025-12-22Clinical Study of Second-line Treatment in Advanced Colorectal Cancer With Chemotherapy With Bevacizumab or CetuximabSecond Affiliated Hospital, School of Medicine, Zhejiang UniversityPhase 2 Recruiting100 enrolled
NCT07012954 2025-06-24ctDNA-Guided Cetuximab or Bevacizumab Plus Trifluridine/Tipiracil in RAS/BRAF Wild-Type mCRCSun Yat-sen UniversityPhase 1/2 Recruiting64 enrolled